FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

IMI plc 12.7% potential upside indicated by Berenberg Bank

March 7, 2024

Rio Tinto plc 20.1% potential upside indicated by RBC Capital Markets

March 7, 2024

easyJet plc 23.8% potential upside indicated by JP Morgan

March 7, 2024

Compass Group plc 18.7% potential upside indicated by JP Morgan

March 7, 2024

INTERCONTINENTAL HOTELS GROUP Common Stock -10.8% potential downside indicated by Berenberg Bank

March 7, 2024

Rentokil Initial plc 15.5% potential upside indicated by RBC Capital Markets

March 7, 2024

International Consolidated Airlns Grp SA 33.9% potential upside indicated by RBC Capital Markets

March 7, 2024

GSK announces positive results from DREAMM-8 phase III trial for Blenrep

GSK plc announces positive results from DREAMM-8 trial evaluating Blenrep in combination with PomDex for multiple myeloma treatment. Exciting news for patients and potential treatment advancements...

March 7, 2024

Aviva plc 2023 results: Profit up 9%, Dividend Growth, and Confident Outlook

Discover Aviva plc's impressive 2023 Results Announcement, showcasing profitable growth and increased dividends. CEO Amanda Blanc highlights key achievements and future enhancements for shareholders and customers...

March 7, 2024

Beazley delivers record $1.25 billion profit in 2023

Beazley plc (LON:BEZ) announces strong financial results for 2023, including record profit and share buyback programme. CFO appointment and future growth plans outlined...

March 7, 2024

ConvaTec Group reports accelerating organic revenue growth of 7.2%

ConvaTec Group plc (LON:CTEC) reports strong annual results with 7.2% organic revenue growth, margin expansion and new product launches...

March 6, 2024

Legal & General reports record new business volumes and resilient in-year profit generation

Legal & General Group Plc unveils its full year 2023 results, highlighting strong performance and future growth opportunities. CEO António Simões shares insights and plans for sustained success...

March 6, 2024

Hiscox Ltd reports Record Profits and Growth in Full-Year Results 2023

Hiscox Ltd (LON:HSX) announced impressive full-year results for 2023, with record profit, strong growth, and a special return to shareholders...

March 5, 2024

Intertek reports highest LFL revenue growth in the last 10 years

Intertek Group plc (LON:ITRK) announces impressive full year results, with revenue growth, margin progression, and strong cash flow. CEO André Lacroix highlights key achievements and outlines positive outlook for 2024...

March 5, 2024

Ashtead Group strong operating performance continues with revenue up 14%

Ashtead Group plc (LON:AHT) delivers strong performance with revenue up 14% and rental revenue up 11% in nine months ending 31 January 2024. CEO Brendan Horgan comments on strategic growth plans and market conditions...

March 5, 2024

GSK ViiV Healthcare reports Positive Findings for ultra long-acting HIV treatment Cabotegravir

GSK plc's ViiV Healthcare announces positive findings from a phase I study on cabotegravir ultra long-acting for HIV treatment. Exciting progress in long-acting medication development...

March 5, 2024

Intertek to acquire Base Met Labs, enhancing minerals testing capabilities

Intertek Group plc announces acquisition of Base Met Labs, a leading provider of metallurgical testing services in North America, enhancing Total Quality Assurance solutions in the Minerals sector...

March 4, 2024

AstraZeneca and Daiichi Sankyo’s Dato-DXd validated by EMA for lung and breast cancer treatment

AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receives EMA validation for lung and breast cancer treatments, advancing the potential for improved patient outcomes...

March 4, 2024

Aviva plc acquires Probitas, entry into Lloyd’s market

Aviva plc (LON:AV) announces the acquisition of Probitas, expanding into the Lloyd's market for growth and profitability. Exciting developments ahead!..

March 4, 2024

Compass Group plc 19.0% potential upside indicated by JP Morgan

March 1, 2024

News and Interview Alerts

Company Presentations

Q&As

Stephane Foucaud Auctus praises “pristine execution” by Valeura Energy (TSX:VLE)

23 April 2024

TEAM plc Chief Investment Officer on Q1 Performance Drivers & Strategy

23 April 2024

Arbuthnot Banking Group’s strategic positioning creates enormous value (LON:ARBB)

23 April 2024

Diversified Energy Company 2023 Results and Financial Outlook: Analyst interview summary (LON:DEC)

19 April 2024

H&T Group Analyst Interview highlights Strong Pawnbroking Growth (LON:HAT)

19 April 2024

Hardman & Co

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Arbuthnot Banking Group 1H’25 results: Growing where it wants to

30 July 2025

Green News

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Smarttech247 Group NoPhish integration with Google Mail an important tool for organisations (VIDEO)

Dekel Agri-vision Lincoln Moore Discusses a Very Positive Start to the Year (LON:DKL) (VIDEO)

Volta Finance What we can learn from the Report and Accounts (VIDEO)

Touchstone Exploration Positive Drilling Results and Momentum (VIDEO)

Pennant International Group CEO Phil Walker

Pennant International CEO Phil Walker on a Positive Trading Update and Optimistic Outlook for 2024 (VIDEO)

Zinc Media Group CEO Mark Browning: Record Earnings and Strategic Diversification (VIDEO)

BrokerTalk

Tern Positive Traction and Growth Highlights Progressive Research’s Gareth Evans

5 June 2024

Cerillion Plc Continued Growth Momentum with Strong Orders and Major Contract Wins

22 May 2024

Union Jack Oil Final Dividend for 2023, Reflecting Strong Cash Flow and Positive Business Outlook

20 May 2024

Cordel Group unveils Asia contract building on strong financial progress (LON:CRDL)

17 May 2024

Norcros plc Exploring the Growth Trajectory with Equity Development

16 May 2024

Funds

Fidelity Asian Values rises further with Hong Kong portfolio enhancing returns

28 October 2025

Fidelity European Trust continued rise as shares advanced in ASML and AIB

28 October 2025

Fidelity Special Values reports 29% share price return over one year beating index (LON:FSV)

28 October 2025

Investing in European Real Estate – RECI Factsheet Sept 2025

24 October 2025

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Bodycote PLC (BOY.L) Stock Analysis: Evaluating a 14.51% Upside Potential in the Industrials Sector

28 October 2025

Baillie Gifford Japan Trust PL (BGFD.L) Stock Analysis: Riding the Edge of a 52-Week High

28 October 2025

Bakkavor Group PLC (BAKK.L) Stock Analysis: Dividend Yield Shines Amidst Industry Challenges

28 October 2025

Chemring Group PLC (CHG.L): Aerospace & Defense Stock with a 6% Upside and Strong Buy Ratings

28 October 2025

Hilton Food Group PLC (HFG.L): Exploring a Potential 48.69% Upside with Strong Dividend Appeal

28 October 2025

FTSE 100

IMI plc 12.7% potential upside indicated by Berenberg Bank

March 7, 2024

Rio Tinto plc 20.1% potential upside indicated by RBC Capital Markets

March 7, 2024

easyJet plc 23.8% potential upside indicated by JP Morgan

March 7, 2024

Compass Group plc 18.7% potential upside indicated by JP Morgan

March 7, 2024

INTERCONTINENTAL HOTELS GROUP Common Stock -10.8% potential downside indicated by Berenberg Bank

March 7, 2024

Rentokil Initial plc 15.5% potential upside indicated by RBC Capital Markets

March 7, 2024

International Consolidated Airlns Grp SA 33.9% potential upside indicated by RBC Capital Markets

March 7, 2024

GSK announces positive results from DREAMM-8 phase III trial for Blenrep

GSK plc announces positive results from DREAMM-8 trial evaluating Blenrep in combination with PomDex for multiple myeloma treatment. Exciting news for patients and potential treatment advancements...

March 7, 2024

Aviva plc 2023 results: Profit up 9%, Dividend Growth, and Confident Outlook

March 7, 2024

Beazley delivers record $1.25 billion profit in 2023

Beazley plc (LON:BEZ) announces strong financial results for 2023, including record profit and share buyback programme. CFO appointment and future growth plans outlined...

March 7, 2024

ConvaTec Group reports accelerating organic revenue growth of 7.2%

ConvaTec Group plc (LON:CTEC) reports strong annual results with 7.2% organic revenue growth, margin expansion and new product launches...

March 6, 2024

Legal & General reports record new business volumes and resilient in-year profit generation

Legal & General Group Plc unveils its full year 2023 results, highlighting strong performance and future growth opportunities. CEO António Simões shares insights and plans for sustained success...

March 6, 2024

Hiscox Ltd reports Record Profits and Growth in Full-Year Results 2023

Hiscox Ltd (LON:HSX) announced impressive full-year results for 2023, with record profit, strong growth, and a special return to shareholders...

March 5, 2024

Intertek reports highest LFL revenue growth in the last 10 years

March 5, 2024

Ashtead Group strong operating performance continues with revenue up 14%

March 5, 2024

GSK ViiV Healthcare reports Positive Findings for ultra long-acting HIV treatment Cabotegravir

GSK plc's ViiV Healthcare announces positive findings from a phase I study on cabotegravir ultra long-acting for HIV treatment. Exciting progress in long-acting medication development...

March 5, 2024

Intertek to acquire Base Met Labs, enhancing minerals testing capabilities

Intertek Group plc announces acquisition of Base Met Labs, a leading provider of metallurgical testing services in North America, enhancing Total Quality Assurance solutions in the Minerals sector...

March 4, 2024

AstraZeneca and Daiichi Sankyo’s Dato-DXd validated by EMA for lung and breast cancer treatment

AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receives EMA validation for lung and breast cancer treatments, advancing the potential for improved patient outcomes...

March 4, 2024

Aviva plc acquires Probitas, entry into Lloyd’s market

Aviva plc (LON:AV) announces the acquisition of Probitas, expanding into the Lloyd's market for growth and profitability. Exciting developments ahead!..

March 4, 2024

Compass Group plc 19.0% potential upside indicated by JP Morgan

March 1, 2024